CAALL-F01: National Protocol for the Treatment of Childhood and Adolescent Acute Lymphoblastic Leukemia (LAL)
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Pegaspargase (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Pharmacokinetics
- Acronyms CAALL F01
- 06 Oct 2017 New trial record